drugset / Trial / NCT04316936

Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery

NCT04316936

RandomizedParallel-groupOpen-labelTreatment

Summary

This research will evaluate the efficacy of Omidria and Dexycu, Omidria and Dextenza, and Omidria and prednisolone acetate 1% in the resolution of post-operative inflammation and pain following cataract surgery.

Timeline

Start
2019-12-10
Primary completion
2020-12-23
Completion
2020-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Subject Dexamethasone Small molecule 9 % Other
Comparator Prednisolone Other / unclassified 1 % Topical
Background Ketorolac Other / unclassified 0.3 % Other
Background Phenylephrine Small molecule 1 % Other

Indications